Home Company People Innovative Products HUCPVC Technologies OsteoScaf™ Corporate Partners Investors News Contact   Tell a Friend: Your Name: Your Friend's Name: Your Friend's Email:     Home > Sitemap     > Home     > Company       > People       > Innovative Products           > Stem Cell Authority Ltd.       > CReATe Cord Blood Bank     > HUCPVC Technologies           > Stem cell       > Mesenchymal stromal cells       > Mesenchymal stem cells       > Treat immune and inflammatory diseases       > HUCPVCs       > National Institutes of Health     > OsteoScaf™           > fully resorbable system       > just like natural bone       > Anti-Inflammatory       > Mechanically strong   > Corporate Partners           > Stem Cell Authority Ltd.       > CReATe Cord Blood Bank   > Investors       > News           > Human Umbilical Cord Perivascular Cells (HUCPVCs)       > Human Umbilical Cord Perivascular Cells are Immunoprivileged and Immunomodulatory in vitro       > TRT announces $20 M Stem Cell License to Stem Cell Authority Ltd. for US Market       > Stem cell licensing deal positions Toronto as world leader in the technology       > Another stem cell first for U of T and Canada       > U of T team discovers stem cell jackpot   > Contact

Home | Company | People | Innovative Products | HUCPVC Technologies | OsteoScaf™ | Corporate Partners | Investors | News | Contact Privacy | Sitemap

© 2007 Tissue Regeneration Therapeutics, Inc.